You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Fluvastatin and Atorvastatin: A Comparison of Patent Protection (Part 2)

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Research article

First published online October, 2007

Fluvastatin and Atorvastatin: A Comparison of Patent Protection (Part 2)

Volume 5, Issue 1

https://doi.org/10.1057/palgrave.jgm.4950092

Abstract

Get full access to this article

View all access options for this article.

References

1.

Howard

L.

(2007). Fluvastatin and Atorvastatin: A comparison of patent protection (Part 1). J Generic Med 4(4), 302–305.

2.

The timing of life-cycle management activities was discussed in a previous article, Howard

L.

(2007). Use of patents in drug lifecycle management. J Generic Med 4(3), 230–236.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Strategic use of Supplementary Protection Certificates (Part 2)

Retricted access

Bayer Healthcare Pharmaceuticals,Inc. v. Watson Pharmaceuticals,Inc. : Was the decision to selectively present evidence of commercial success too “clever by half”?

Retricted access

Introduction to the America Invents Act

Retricted access

Palmetto v. AstraZeneca : The scope of intent as a claim element